Cizzle Biotechnology Holdings Plc (FRA:E7F0)

Market Cap	11.82M +45.2%
Revenue (ttm)	n/a
Net Income	-792.09K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0250
Previous Close	0.0255
Day's Range	0.0250 - 0.0250
52-Week Range	0.0125 - 0.0395
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About FRA:E7F0

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Employees: 5
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E7F0

Financial Performance

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error